KCNMB4: A Potential Drug Target and Biomarker (G27345)

Target Name: KCNMB4

NCBI ID: G27345

KCNMB4

KCNMB4: A Potential Drug Target and Biomarker

KCNMB4, also known as maxi K channel subunit beta-4, is a gene that encodes a protein involved in the intracellular signaling pathway known as the potassium channel pathway. This pathway plays a crucial role in regulating various cellular processes, including muscle contractions, nerve function, and even cell survival. The encoded protein is expressed in many different tissues and cells throughout the body, making it a potential drug target or biomarker.

KCNMB4 function

The KCNMB4 gene encodes a protein that is composed of 115 amino acid residues. This protein is localized to the endoplasmic reticulum (ER), where it is involved in the regulation of various cellular processes. The most well-studied function of this protein is its role in the regulation of sodium and potassium channels.

KCNMB4 is a member of the K channel subfamily, which is a large family of proteins that are involved in the regulation of electrical activity in various cells. The K channel subfamily includes several different subunits, each with its own unique function. KCNMB4 is specifically involved in the regulation of the activity of the beta-4 subunit.

KCNMB4 is involved in the regulation of several different processes in the body, including:

1. Muscle contractions: KCNMB4 is involved in the regulation of muscle contractions and is thought to play a role in the development of muscle weakness and myopathies.
2. Nerve function: KCNMB4 is involved in the regulation of nerve function and is thought to play a role in the development of neurodegenerative diseases.
3. Cell survival: KCNMB4 is involved in the regulation of cell survival and is thought to play a role in the development of cancer.

Drug targeting and biomarker potential

KCNMB4 has been identified as a potential drug target due to its involvement in the regulation of various cellular processes. By blocking the activity of KCNMB4, researchers can potentially interfere with the regulation of these processes and lead to therapeutic effects.

One approach to targeting KCNMB4 is through the use of small molecules, such as those that bind to specific regions of the protein. These small molecules can either inhibit or activate the activity of KCNMB4, leading to changes in cellular behavior.

Another approach to targeting KCNMB4 is through the use of antibodies that recognize and label the protein. These antibodies can then be used to either activate or inhibit the activity of KCNMB4, depending on the desired effect.

As a potential drug target, KCNMB4 has the potential to be used to treat a variety of conditions, including muscle weakness, neurodegenerative diseases, and cancer.

Biomarker potential

In addition to its potential as a drug target, KCNMB4 also has the potential as a biomarker. The regulation of sodium and potassium channels is a critical aspect of many cellular processes, including muscle contractions, nerve function, and even cell survival. As such, the activity of KCNMB4 may be a useful indicator of the health and function of cells.

Research has shown that changes in the level of KCNMB4 can be associated with a variety of cellular processes, including muscle weakness, neurodegenerative diseases, and cancer. Therefore, the level of KCNMB4 may be a useful biomarker for these conditions.

Conclusion

KCNMB4 is a gene that encodes a protein involved in the intracellular signaling pathway known as the potassium channel pathway. This pathway plays a crucial role in regulating various cellular processes, including muscle contractions, nerve function, and even cell survival. As such, KCNMB4 has the potential to be a drug target or biomarker. Additionally, the regulation of sodium and potassium channels by KCNMB4 is a critical aspect of many cellular processes, making it a potential indicator of cellular health and function. Further research is needed to fully understand the role of KCNMB4 in these processes and its potential as a drug target or biomarker.

Protein Name: Potassium Calcium-activated Channel Subfamily M Regulatory Beta Subunit 4

Functions: Regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel diversity. Decreases the gating kinetics and calcium sensitivity of the KCNMA1 channel, but with fast deactivation kinetics. May decrease KCNMA1 channel openings at low calcium concentrations but increases channel openings at high calcium concentrations. Makes KCNMA1 channel resistant to 100 nM charybdotoxin (CTX) toxin concentrations

The "KCNMB4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNMB4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets